1. Home
  2. MREO vs APT Comparison

MREO vs APT Comparison

Compare MREO & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.30

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

SELL

Current Price

$6.50

Market Cap

55.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
MREO
APT
Founded
2015
1983
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
55.3M
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
MREO
APT
Price
$0.30
$6.50
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $1.96
N/A
AVG Volume (30 Days)
★ 632.5K
46.6K
Earning Date
11-09-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
N/A
★ 0.43
Revenue
$500,000.00
★ $59,142,000.00
Revenue This Year
$59.51
N/A
Revenue Next Year
$2,326.81
N/A
P/E Ratio
★ N/A
$14.37
Revenue Growth
N/A
★ 2.25
52 Week Low
$0.20
$4.34
52 Week High
$2.37
$7.50

Technical Indicators

Market Signals
Indicator
MREO
APT
Relative Strength Index (RSI) 50.90 68.97
Support Level $0.27 $4.99
Resistance Level $0.35 $6.36
Average True Range (ATR) 0.02 0.29
MACD 0.00 0.08
Stochastic Oscillator 62.55 83.20

Price Performance

Historical Comparison
MREO
APT

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.

Share on Social Networks: